Mammadbayli, Najaf
Altunay, Betül
Peña, Quim
Kobzev, Dmytro
Morgenroth, Agnieszka
Sadeghzadeh, Masoud
Lammers, Twan
Mottaghy, Felix Manuel
Schäfer, Laura
Lütje, Susanne
Funding for this research was provided by:
Universitätsklinikum RWTH Aachen
Article History
Received: 11 November 2025
Accepted: 10 February 2026
First Online: 3 March 2026
Declarations
:
: Not applicable.
: Not applicable.
: Felix Manuel Mottaghy is medical advisor for NanoMab Technology Ltd. and Advanced Accelerator Applications (AAA) GmbH/Novartis and has recently received institutional grants from NanoMab Technology Ltd., Radiopharm Theranostics, Siemens, and GE Precision HealthCare LLC.